Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Aim. Despite the beneficial effects of dietary restriction (DR) on lifespan, age-related diseases, including diabetes and cardiovascular diseases, its effects on type 2 diabetic nephropathy remain unknown. This study examined the renoprotective effects of DR in Wistar fatty (fa/fa) rats (WFRs).Methods. WFRs were treated with DR (40% restriction) for 24 weeks. Urinary albumin excretion, creatinine clearance, renal histologies, acetylated-NF-κ B (p65), Sirt1 protein expression, and p62/Sqstm 1 accumulation in the renal cortex, as well as electron microscopic observation of mitochondrial morphology and autophagosomes in proximal tubular cells were estimated.Results. DR ameliorated renal abnormalities including inflammation in WFRs. The decrease in Sirt1 levels, increase in acetylated-NF-κ B, and impaired autophagy in WFRs were improved by DR.Conclusions. DR exerted anti-inflammatory effects and improved the dysregulation of autophagy through the restoration of Sirt1 in the kidneys of WFRs, which resulted in the amelioration of renal injuries in type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, in diabetic Wistar fatty rats, impaired autophagy in PTECs was reversed by a very-low-protein diet and by a daily 40% restriction of the food consumption, which suppressed mTORC1 and activated SIRT1 pathways, respectively”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [152]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“resulting in an attenuation of DKD-related tubular injury and kidney dysfunction152,153.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [152]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452 · cited 2×
“In addition, autophagy is a major intracellular process in which lysises in sthe damaged cytoplasmic organelles, including mitochondria, degrade protein aggregates and aged proteins [8, 9].”
BackgroundAutophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506 · cited 5×
“Under normal circumstances, damaged mitochondria are degraded by the intracellular autophagy pathway [8].”
BackgroundInfluentialAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023 · cited 2×
“Dietary restriction (DR) has a variety of effects on lifespan extension and the delayed onset of age-related diseases, including cardiovascular diseases and diabetes, and is accepted as the only established antiaging experimental paradigm [3, 4].”
BackgroundCaloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277 · cited 2×
“also reported that DR delayed the onset of ageassociated pathologies, including diabetes and cardiovascular disease, in rhesus monkeys [4].”
BackgroundCalorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924 · cited 1×
“What is the other factor? We here focused on Sirt1 as the other factor induced by DR because DR is known to significantly increase the levels of Sirt1 protein expression in most tissues, including the kidney, and the beneficial effects of DR are linked to Sirt1 activation [5, 6, 22].”
BackgroundLin, S.-J., Defossez, P.-A., & Guarente, L. (2000) · Science · doi:10.1126/science.289.5487.2126 · Cited by 1,775 · cited 1×
“What is the other factor? We here focused on Sirt1 as the other factor induced by DR because DR is known to significantly increase the levels of Sirt1 protein expression in most tissues, including the kidney, and the beneficial effects of DR are linked to Sirt1 activation [5, 6, 22].”
BackgroundAutophagy Suppresses Tumorigenesis through Elimination of p62
Mathew, R., Karp, C. M., Beaudoin, B., Vuong, N., Chen, G., Chen, H.-Y., Bray, K., Reddy, A., Bhanot, G., Gelinas, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.048 · Cited by 1,719
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222 · cited 2×
“The p65 subunit of NF-κB selectively interacts with Sirt1, which promotes the deacetylation of the p65 subunit and leads to the attenuation of the transcriptional activity of NF-κB and inflammation [23].”
BackgroundInflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072 · cited 2×
“The inflammatory process is one of the pivotal mechanisms for the initiation and progression of diabetic nephropathy and atherosclerosis [2].”
Background
Cited by
Bhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., & Reddy, P. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.019 · Cited by 693
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
DeFronzo, R. A., Reeves, W. B., & Awad, A. S. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00393-8 · Cited by 589
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Hasegawa, K., Wakino, S., Simic, P., Sakamaki, Y., Minakuchi, H., Fujimura, K., Hosoya, K., Komatsu, M., Kaneko, Y., Kanda, T., et al. (2013) · Nature Medicine · doi:10.1038/nm.3363 · Cited by 483
Calorie restriction and sirtuins revisited
Guarente, L. (2013) · Genes & Development · doi:10.1101/gad.227439.113 · Cited by 464
“As a final proof of principle, administering resveratrol directly to the CNS of rodents mediates insulin sensitivity, and this effect is abolished by knocking down SIRT1 expression in the hypothalamus (Knight et al. 2011).”
BackgroundAKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms
He, L., Wei, Q., Liu, J., Yi, M., Liu, Y., Liu, H., Sun, L., Peng, Y., Liu, F., Venkatachalam, M. A., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.06.030 · Cited by 448
Seven sirtuins for seven deadly diseases ofaging
Morris, B. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.525 · Cited by 377
“inflammation, ameliorates renal injuries in diabetic Wistar fa/fa rats [347].”
BackgroundVallon, V., Rose, M., Gerasimova, M., Satriano, J., Platt, K. A., Koepsell, H., Cunard, R., Sharma, K., Thomson, S. C., & Rieg, T. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00409.2012 · Cited by 370
Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease
Chen, J., Zeng, F., Forrester, S. J., Eguchi, S., Zhang, M.-Z., & Harris, R. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00030.2015 · Cited by 327
Autophagy in diabetic nephropathy
Ding, Y., & Choi, M. E. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0437 · Cited by 306
Lenoir, O., Jasiek, M., Hénique, C., Guyonnet, L., Hartleben, B., Bork, T., Chipont, A., Flosseau, K., Bensaada, I., Schmitt, A., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1049799 · Cited by 296
“Although they affect many pathways besides autophagy, several studies have shown that these treatments have positive effects on inflammation, tubular injury, glomerulosclerosis, and podocyte injury in rodent models of DN.(73-80) Interestingly, Wen et al.”
BackgroundAutophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
Yang, D., Livingston, M. J., Liu, Z., Dong, G., Zhang, M., Chen, J.-K., & Dong, Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2639-1 · Cited by 252
“Dietary restriction rescued autophagy deficiency via the suppression of mTORC1 and activation of SIRT1 pathways, and thereby ameliorated tubulointerstitial damage and renal function loss in these obese rats [56, 83].”
BackgroundResultInfluentialMitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?
Higgins, G. C., & Coughlan, M. T. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12503 · Cited by 250
“, 2013) and Wistar fatty (fa/fa) rats (Kitada et al., 2011), a model of type 2 diabetes.”
BackgroundRodent models of diabetic nephropathy: their utility and limitations
Kitada, M., Ogura, Y., & Koya, D. (2016) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s103784 · Cited by 241
Self-citationEbrahim, N., Ahmed, I., Hussien, N., Dessouky, A., Farid, A., Elshazly, A., Mostafa, O., Gazzar, W., Sorour, S., Seleem, Y., et al. (2018) · Cells · doi:10.3390/cells7120226 · Cited by 235
“…antibody [37], anti-LC3-I/II antibody (ABC929, Sigma-Aldrich), rabbit polyclonal antibody [38], anti-S6K1 antibody (ab9366), rabbit polyclonal antibody [39], anti-SQSTM1/p62 antibody (ab155686), rabbit polyclonal antibody [40] and anti-mTOR antibody (ab2732), rabbit polyclonal antibody [41]).”
Backgroundp53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease
Ma, Z., Li, L., Livingston, M. J., Zhang, D., Mi, Q., Zhang, M., Ding, H.-F., Huo, Y., Mei, C., & Dong, Z. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135536 · Cited by 220
Sirtuins and renal diseases: relationship with aging and diabetic nephropathy
Kitada, M., Kume, S., Takeda-Watanabe, A., Kanasaki, K., & Koya, D. (2013) · Clinical Science · doi:10.1042/cs20120190 · Cited by 207
Self-citationSirt1 Activation Ameliorates Renal Fibrosis by Inhibiting the TGF‐β/Smad3 Pathway
Huang, X., Wen, D., Zhang, M., Xie, Q., Ma, L., Guan, Y., Ren, Y., Chen, J., & Hao, C. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24748 · Cited by 200
“, 2010], diabetic nephropathy [Kitada et al., 2011], and unilateral ureteral obstruction (UUO) [He et al.”
BackgroundSirtuins' modulation of autophagy
Ng, F., & Tang, B. L. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24399 · Cited by 196
“The term autophagocytosis or autophagy refers generally to conserved cellular processes whereby cytoplasmic contents and organelles are sequestered within a double-membrane autophagosome and subsequently degraded at the vacuole or lysosome (Klionsky and Emr, 2000; Yang and Klionsky, 2010a).”
BackgroundDiabetic Kidney Disease: Pathophysiology and Therapeutic Targets
Toth-Manikowski, S., & Atta, M. G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/697010 · Cited by 192
“Dietary restriction in rats was shown to improve urinary albumin excretion and creatinine clearance and increase levels of Sirt1, a positive regulator of autophagy [89].”
BackgroundDiabetic Nephropathy: a Tangled Web to Unweave
Magee, C., Grieve, D. J., Watson, C. J., & Brazil, D. P. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6755-9 · Cited by 190
“Indeed, calorie restriction in diabetic rats proved to regulate disordered autophagy by upregulating sirtuin 1 [130] and by suppressing”
BackgroundEmpagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy
Lee, Y. H., Kim, S. H., Kang, J. M., Heo, J. H., Kim, D.-J., Park, S. H., Sung, M., Kim, J., Oh, J., Yang, D. H., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00565.2018 · Cited by 189
Autophagy in Chronic Kidney Diseases
Lin, T.-A., Wu, V. C.-C., & Wang, C.-Y. (2019) · Cells · doi:10.3390/cells8010061 · Cited by 188
“In proximal tubular cells, autophagy activation is reduced by hyperglycemia while p62 is increased in both type 1 and type 2 diabetes animal models [59,60].”
BackgroundTanaka, S., Sugiura, Y., Saito, H., Sugahara, M., Higashijima, Y., Yamaguchi, J., Inagi, R., Suematsu, M., Nangaku, M., & Tanaka, T. (2018) · Kidney International · doi:10.1016/j.kint.2018.04.025 · Cited by 166
“Calorie restriction and autophagy activation have been reported to improve kidney hypertrophy, macrophage infiltration, and tubulointerstitial fibrosis in Wistar fatty rats and aged mice.(17,18) Failure to activate autophagy with SGLT2 inhibition should be related to the fact that the difference in urinary glucose was…”
BackgroundDiet and Chronic Kidney Disease
Kramer, H. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz011 · Cited by 160
“Autophagy suppression results in reduced mitochondrial quality, and these damaged mitochondria accumulate in tubular cells of the kidney, which then incites inflammation and oxidative stress (43).”
BackgroundNutrient Sensing, Autophagy, and Diabetic Nephropathy
Kume, S., Thomas, M. C., & Koya, D. (2012) · Diabetes · doi:10.2337/db11-0555 · Cited by 157
“As a potential proof of concept, intermittent fasting in a streptozotocin-induced and Wister fatty rats is associated with increased renal SIRT1 activity and renoprotection (40,64).”
BackgroundSelf-citationAutophagy in kidney disease and aging: lessons from rodent models
Lenoir, O., Tharaux, P.-L., & Huber, T. B. (2016) · Kidney International · doi:10.1016/j.kint.2016.04.014 · Cited by 148
Huang, K., Gao, X., & Wei, W. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.09.042 · Cited by 155
Zhang, M.-Z., Wang, Y., Paueksakon, P., & Harris, R. C. (2014) · Diabetes · doi:10.2337/db13-1279 · Cited by 151
“Although some investigators have suggested that autophagy might play a pathogenic role (27), others have suggested that autophagy is protective (28).”
BackgroundRegulation of Autophagy by TGF-β: Emerging Role in Kidney Fibrosis
Ding, Y., & Choi, M. E. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.11.009 · Cited by 139
Role of sirtuin-1 in diabetic nephropathy
Wang, W., Sun, W., Cheng, Y., Xu, Z., & Cai, L. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01743-7 · Cited by 144
“Previous studies showed that calorie restriction (CR) has beneficial effects on DN via AMPK and sirtuin-1 [51].”
BackgroundBarutta, F., Bellini, S., Kimura, S., Hase, K., Corbetta, B., Corbelli, A., Fiordaliso, F., Bruno, S., Biancone, L., Barreca, A., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2080382 · Cited by 141
Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice
Hong, Y. A., Lim, J. H., Kim, M. Y., Kim, T. W., Kim, Y., Yang, K. S., Park, H. S., Choi, S. R., Chung, S., Kim, H. W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096147 · Cited by 118
Mitochondria in Diabetic Kidney Disease
Ahmad, A. A., Draves, S. O., & Rosca, M. G. (2021) · Cells · doi:10.3390/cells10112945 · Cited by 126
Ji, L.-Q., Chen, Y., Wang, H., Zhang, W., He, L., Wu, J.-M., & Liu, Y. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4800 · Cited by 122
“Several studies have demonstrated that the expression of Sirt1 in DN decreases, and that the increased Sirt1 expression can attenuate renal injury in DN (48-51).”
BackgroundRegulation of TFEB activity and its potential as a therapeutic target against kidney diseases
Zhang, W., Li, X., Wang, S., Chen, Y., & Liu, H. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0265-4 · Cited by 121
Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease
Wang, Y., Zheng, Z.-J., Jia, Y.-J., Yang, Y.-L., & Xue, Y.-M. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1486-7 · Cited by 115
“Cell Sirt1 expression was decreased, autophagy was impaired, tubular cell injury was induced [20], and P53 was also involved [21] as downstream regulator of sirt1 [22, 23].”
Mechanisms and biological functions of autophagy in diseased and ageing kidneys
Fougeray, S., & Pallet, N. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.201 · Cited by 115
Autophagy as a Therapeutic Target in Diabetic Nephropathy
Tanaka, Y., Kume, S., Kitada, M., Kanasaki, K., Uzu, T., Maegawa, H., & Koya, D. (2012) · Experimental Diabetes Research · doi:10.1155/2012/628978 · Cited by 111
“Actually, a recent report has shown abnormal mitochondrial morphology in diabetic kidney [95, 104], suggesting that diabetic kidney fails to remove damaged mitochondria.”
BackgroundSelf-citationAutophagy: A Novel Therapeutic Target for Diabetic Nephropathy
Kume, S., & Koya, D. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.6.451 · Cited by 116
“Indeed, calorie restriction improves renal damage in type 2 diabetic Wistar fatty rats, as well as restoring autophagy activity in their proximal tubular cells [48].”
BackgroundSelf-citationRegulating Autophagy as a Therapeutic Target for Diabetic Nephropathy
Kitada, M., Ogura, Y., Monno, I., & Koya, D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0879-y · Cited by 108
Self-citationAccelerated Kidney Aging in Diabetes Mellitus
Guo, J., Zheng, H. J., Zhang, W., Lou, W., Xia, C., Han, X. T., Huang, W. J., Zhang, F., Wang, Y., & Liu, W. J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1234059 · Cited by 93
“These results demonstrated that dietary restriction-mediated Sirt1 restoration exerted anti-inflammatory effects and improved autophagy dysregulation, which resulted in the amelioration of renal injuries in DM [76].”
BackgroundAutophagy in Kidney Health and Disease
Wang, Z., & Choi, M. E. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5363 · Cited by 100
Guo, H., Wang, Y., Zhang, X., Zang, Y., Zhang, Y., Wang, L., Wang, H., Wang, Y., Cao, A., & Peng, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-07061-7 · Cited by 104
SIRT1 inactivation induces inflammation through the dysregulation of autophagy in human THP-1 cells
Takeda‐Watanabe, A., Kitada, M., Kanasaki, K., & Koya, D. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.042 · Cited by 103
Self-citationThe Role of SIRT1 in Diabetic Kidney Disease
Yacoub, R., Lee, K., & He, J. C. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00166 · Cited by 92
“Dietary restriction in Wistar fatty rates restores Sirt1 expression and ameliorates diabetic nephropathy abnormalities (i.e., albuminuria, mesangial matrix expansion, and renal fibrosis), which is in part mediated by Sirt1’s antiinflammatory effects as evidenced by decreased macrophages infiltrates and changes in expr…”
BackgroundInfluentialSIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease
Zhong, Y., Lee, K., & He, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00624 · Cited by 99
“Resveratrol was shown to attenuate DKD through activation of AMPK/SIRT1 pathway (29, 31) and by modulating angiogenesis (43).”
BackgroundNing, Y., Cai, G., Zhuo, L., Gao, J., Dong, D. F., Cui, S., Feng, Z., Shi, S., Bai, X., Sun, X., et al. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.11.006 · Cited by 98
“SIRT1, AMP-activated protein kinase (AMPK) and mTOR are all linked to the beneficial effects of CR in most tissues, including the kidney (Blagosklonny, 2010; Kitada et al., 2011; Kume et al., 2010; Martin-Montalvo and de Cabo, 2012).”
BackgroundKitada, M., Ogura, Y., Suzuki, T., Sen, S., Lee, S. M., Kanasaki, K., Kume, S., & Koya, D. (2016) · Diabetologia · doi:10.1007/s00125-016-3925-4 · Cited by 97
Self-citationProximal Tubule Autophagy Differs in Type 1 and 2 Diabetes
Sakai, S., Yamamoto, T., Takabatake, Y., Takahashi, A., Namba-Hamano, T., Minami, S., Fujimura, R., Yonishi, H., Matsuda, J., Hesaka, A., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018100983 · Cited by 96
Maeda, S., Matsui, T., Takeuchi, M., & Yamagishi, S. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2407 · Cited by 90
CoQ10 ameliorates mitochondrial dysfunction in diabetic nephropathy through mitophagy
Sun, J. M., Zhu, H., Wang, X., Gao, Q., Li, Z., & Huang, H. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0578 · Cited by 91
The Role of Autophagy in the Pathogenesis of Diabetic Nephropathy
Yamahara, K., Yasuda, M., Kume, S., Koya, D., Maegawa, H., & Uzu, T. (2013) · Journal of Diabetes Research · doi:10.1155/2013/193757 · Cited by 85
“regulation of autophagy via restoration of sirt1 in diabetic Wistar fatty (fa/fa) rats [72].”
BackgroundSelf-citationSirtuin 1: A Target for Kidney Diseases
Kong, L., Wu, H., Zhou, W., Luo, M., Tan, Y., Miao, L., & Cai, L. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00211 · Cited by 87
“Evidence also indicated that renal inflammation was induced by increased levels of acetylated NF-κB p65 owing to reduced SIRT1 protein expression, whereas dietary restriction exerted antiinflammatory effects by restoring SIRT1 expression in the kidney of the diabetic Wistar fatty (fa/fa) rat (77).”
BackgroundQuercetin alleviates high glucose-induced Schwann cell damage by autophagy
Qu, L., Liang, X., Gu, B., & Liu, W. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.135328 · Cited by 81
“…(Marsh et al., 2007; Ebato et al., 2008; Fujimoto et al., 2009; Masini et al., 2009; Lo et al., 2010; Ost et al., 2010; Younce et al., 2010; Kitada et al., 2011; Mellor et al., 2011; Peng et al., 2011; Wu et al., 2011; Xie et al., 2011; He et al., 2012; Hu et al., 2012; Miranda et al.,…”
Lin, Y., Kuro‐o, M., & Sun, Z. (2013) · Endocrinology · doi:10.1210/en.2013-1053 · Cited by 85
“It was reported that upregulation of autophagy is involved in the amelioration of diabetic nephropathy by food restriction (35).”
Background3,5-Diiodo-l-thyronine ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats
Shang, G., Gao, P., Zhao, Z., Chen, Q., Jiang, T., Zhang, N., & Li, H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.023 · Cited by 84
Drosophila melanogasteras a Model for Diabetes Type 2 Progression
Álvarez-Rendón, J. P., Salceda, R., & Riesgo‐Escovar, J. R. (2018) · BioMed Research International · doi:10.1155/2018/1417528 · Cited by 84
Lu, X., Fan, Q., Li, X., Lin, L., Yue, Y., Xu, Y., Su, Y. R., Zhang, D., & Wang, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117400 · Cited by 82
“When injured or senescent organelles (such as mitochondria) or macromolecules (such as proteins) in cells cannot be efficiently cleared, large amounts of these substances accumulate inside cells, aggravating cell injury and promoting senescence [43,44].”
BackgroundRenal Protective Effect of Sirtuin 1
Dong, Y., Liu, N., Xiao, Z., Sun, T., Wu, S., Sun, W., Xu, Z., & Yuan, H. (2014) · Journal of Diabetes Research · doi:10.1155/2014/843786 · Cited by 82
“[22] detected a decrease in mitochondrial autophagy in the renal proximal tubule cells of diabetic rats subjected to calorie restriction.”
BackgroundLiu, H., Kao, H.-H., & Wu, C.-H. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0349-4 · Cited by 82
Cell Apoptosis and Autophagy in Renal Fibrosis
Zhao, X., Livingston, M. J., Liang, X., & Dong, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_28 · Cited by 78
The Role of Sirtuins in Kidney Diseases
Hong, Y. A., Kim, J. E., Jo, M.-J., & Ko, G.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186686 · Cited by 77
“Dietary restriction in diabetic rat models increased SIRT1 expression in the kidneys and improved renal function including albuminuria, creatinine clearance, and renal histology [117,118].”
BackgroundDiverse therapeutic efficacies and more diverse mechanisms of nicotinamide
Song, S. B., Park, J., Chung, G. J., Lee, I. H., & Hwang, E. S. (2019) · Metabolomics · doi:10.1007/s11306-019-1604-4 · Cited by 78
Cellular and molecular mechanisms of diabetic glomerulopathy
Gnudi, L. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs121 · Cited by 76
“Similarly, dietary restriction, as opposed to excess of nutrients availability for cells in diabetes (glucose toxicity), is associated with Sirt1 up-regulation and amelioration of DN [40, 45].”
BackgroundAnti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy
Kume, S., Kitada, M., Kanasaki, K., Maegawa, H., & Koya, D. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0019-4 · Cited by 72
Self-citationLiu, H., Wang, Q., Shi, G., Yang, W., Zhang, Y., Chen, W., Wan, S., Xiong, F., & Wang, Z. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s299375 · Cited by 71
“of rapamycin (mTOR) and AMP activated protein kinase (AMPK) signaling pathway.(17) And autophagy can be pro-”
BackgroundJiang, X.-S., Xiang, X.-Y., Chen, X., He, J., Liu, T., Gan, H., & Du, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2594-x · Cited by 71
Autophagy-nutrient sensing pathways in diabetic complications
Parmar, U. M., Jalgaonkar, M. P., Kulkarni, Y. A., & Oza, M. J. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106408 · Cited by 70
Mitochondrial Reactive Oxygen Species and Kidney Hypoxia in the Development of Diabetic Nephropathy
Schiffer, T. A., & Friederich‐Persson, M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00211 · Cited by 70
“In a rat type 2 diabetes model, p62/SQSTM1 was increased (Kitada et al., 2011) and reduced levels of autophagy markers were observed in mouse glomerular lysates 28 days after streptozotocin injection (Fang et al.”
BackgroundSirtuins and Renal Oxidative Stress
Ogura, Y., Kitada, M., & Koya, D. (2021) · Antioxidants · doi:10.3390/antiox10081198 · Cited by 69
Self-citationSodium-glucose cotransporter 2 inhibitors and mitochondrial functions: state of the art
Yaribeygi, H., Maleki, M., Butler, A. E., Jamialahmadi, T., & Sahebkar, A. (2023) · EXCLI journal · doi:10.17179/excli2022-5482 · Cited by 70
“Most diabetic complications, examples being diabetic nephropathy and atherosclerosis, are associated with a reduced mitochondrial mass and lowered rate of ATP synthesis (Kitada et al., 2011; DeBarmore et al., 2020).”
Unbreak My Heart: Targeting Mitochondrial Autophagy in Diabetic Cardiomyopathy
Kubli, D. A., & Gustafsson, Å. B. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6322 · Cited by 64
“Caloric restriction in the T2D Wistar Fatty (fa/fa) rat model also increases SIRT1 activity and mitophagy in the kidney, and it prevents the development of nephropathy (83).”
BackgroundAutophagy: Emerging Therapeutic Target for Diabetic Nephropathy
Kume, S., Yamahara, K., Yasuda, M., Maegawa, H., & Koya, D. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.11.003 · Cited by 68
Self-citationReciprocal Crosstalk Between Autophagic and Endocrine Signaling in Metabolic Homeostasis
Sinha, R. A., Singh, B. K., & Yen, P. M. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1103 · Cited by 67
“Similar to podocytes, experimental models with loss of autophagy in the proximal tubular cells also showed progressive renal failure (269-274).”
ResultDeng, Z., Wang, Z., Jin, J., Wang, Y., Bao, N., Gao, Q., & Zhao, J. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.051 · Cited by 67
“648 [72] Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K, Koya D.”
BackgroundProtective role of mitoquinone against impaired mitochondrial homeostasis in metabolic syndrome
Yang, J., Suo, H., & Song, J. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1809344 · Cited by 66
Protective or Harmful: The Dual Roles of Autophagy in Diabetic Retinopathy
Gong, Q., Wang, H., Yu, P., Qian, T., & Xu, X. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.644121 · Cited by 65
“Autophagy was inhibited in proximal tubules of STZ-induced early diabetic rats, related to tubular hypertrophy (115).”
BackgroundSirtuins at the Service of Healthy Longevity
Watroba, M., & Szukiewicz, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.724506 · Cited by 64
“SIRT1 can exert such effect through deacetylation of p65 subunit of NF-κB (Kitada et al., 2011; Kauppinen et al., 2013), while SIRT3 may exert anti-inflammatory effect through acting on NRLP3 inflammasome, reducing ROS concentration and proinflammatory cytokine production (Yang et al., 2016; Zhao…”
BackgroundTheobromine increases NAD+/Sirt-1 activity and protects the kidney under diabetic conditions
Papadimitriou, A., Silva, K. C., Peixoto, E. B. M. I., Borges, C. M., de Faria, J. M. L., & de Faria, J. B. L. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00252.2014 · Cited by 64
Claude‐Taupin, A., Isnard, P., Bagattin, A., Kuperwasser, N., Roccio, F., Ruscica, B., Goudin, N., Garfa‐Traoré, M., Regnier, A., Turinsky, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43775-1 · Cited by 64
Role of Nutrient-Sensing Signals in the Pathogenesis of Diabetic Nephropathy
Kume, S., Koya, D., Uzu, T., & Maegawa, H. (2014) · BioMed Research International · doi:10.1155/2014/315494 · Cited by 60
“Based on more recent reports, Sirt1 activity is likely to be suppressed in the kidney of diabetic animal models [43, 51].”
BackgroundSelf-citationMitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets
Apostolova, N., Vezza, T., Muntane, J., Rocha, M., & Víctor, V. M. (2023) · Antioxidants & Redox Signaling · doi:10.1089/ars.2022.0016 · Cited by 58
“…nephropathy, manifested as an accumulation of p62/SQSTM1 protein in the glomeruli (Tagawa et al, 2016), and the same was observed in a diabetes nephropathy rat model with severe proteinuria (Tagawa et al, 2016), and in the kidneys of diabetic Wistar fatty ( fa/fa ) rats (Kitada et al, 2011).”
Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic Nephropathy
Li, X., Li, C., & Sun, G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4065382 · Cited by 62
“SIRT1 NF-κB, STAT3 Renal tubular cells, podocyte; GMCs; db/db mice; diabetic fa/fa rats Attenuating albuminuria; inhibiting cell apoptosis; attenuating kidney injury; regulating autophagy; reducing oxidative stress [47, 75– 80, 82–84]”
BackgroundHigh glucose up-regulates microRNA-34a-5p to aggravate fibrosis by targeting SIRT1 in HK-2 cells
Xue, M., Li, Y., Hu, F., Jia, Y., Zheng, Z., Wang, L., & Xue, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.048 · Cited by 61
Acute Hyperglycemia May Induce Renal Tubular Injury Through Mitophagy Inhibition
Wang, J., Yue, X., Meng, C., Wang, Z., Jin, X., Cui, X., Yang, J., Shan, C., Gao, Z., Yang, Y., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.536213 · Cited by 59
Alzahrani, S., Zaitone, S. A., Said, E., El‐Sherbiny, M., Ajwah, S. M., Alsharif, S. Y., & Elsherbiny, N. M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106813 · Cited by 59
SIRT1 Regulates CD40 Expression Induced by TNF-a via NF-?B Pathway in Endothelial Cells
Yang, L., Zhang, J., Yan, C., Zhou, J., Lin, R., Lin, Q., Wang, W., Zhang, K., Yang, G., Bian, X., et al. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000343318 · Cited by 58
Jaikumkao, K., Promsan, S., Thongnak, L., Swe, M. T., Tapanya, M., Htun, K. T., Kothan, S., Intachai, N., & Lungkaphin, A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30316 · Cited by 58
“inhibited in early diabetic rats, with associated renal mTOR and p62 activation which induced kidney dysfunction (Huang et al., 2017; Kitada et al., 2011; Vallon et al., 2013).”
BackgroundSIRT1: a promising therapeutic target in type 2 diabetes mellitus
Mihanfar, A., Akbarzadeh, M., Darband, S. G., Sadighparvar, S., & Majidinia, M. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1956976 · Cited by 56
“Taking together, SIRT1 plays a critical function in diabetic nephropathy and is suggested to be a therapeutic target for reversing this chronic diabetes-related disorder (Kitada et al ., 2011, Kim et al ., 2013).”
BackgroundHigh Dose Vitamin E Attenuates Diabetic Nephropathy via Alleviation of Autophagic Stress
Zhao, Y., Zhang, W., Jia, Q., Feng, Z., Guo, J., Han, X., Liu, Y., Shang, H., Wang, Y., & Liu, W. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01939 · Cited by 56
“The accumulation of autophagic substrate p62/SQSTM1 has been observed in the kidneys of diabetic mice induced by STZ (Vallon et al., 2013), Wistar fatty rats (Kitada et al., 2011) and diabetic patients (Yamahara et al., 2013; Huang et al., 2014, 2016).”
BackgroundPotential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease
Tovar‐Palacio, C., Noriega, L. G., & Mercado, A. (2022) · Nutrients · doi:10.3390/nu14030653 · Cited by 55
“Interestingly, a recent study reported that resveratrol protected against DKD in an AMPK/SIRT1-independent pathway in db/db mouse models of type 2 diabetes [24].”
BackgroundHydrogen sulfide modulates SIRT1 and suppresses oxidative stress in diabetic nephropathy
Ahmed, H. H., Taha, F., Omar, H. S., Elwi, H. M., & Abdelnasser, M. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03506-x · Cited by 54
Zheng, X.-P., Qing, N., Feng, J., Fan, X., Jin, Y., Chen, G., & Du, J. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01833-6 · Cited by 54
Wang, X., Wu, L., Zhao, L., Sun, L., Liu, H., Liu, G., & Guan, G. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.009 · Cited by 53
The Physiological Role of Irisin in the Regulation of Muscle Glucose Homeostasis
Yano, N., Zhao, Y., & Zhao, T. C. (2021) · Endocrines · doi:10.3390/endocrines2030025 · Cited by 53
In Vivo RNA Interference Models of Inducible and Reversible Sirt1 Knockdown in Kidney Cells
Chuang, P. Y., Xu, J., Dai, Y., Jia, F., Mallipattu, S. K., Yacoub, R., Gu, L., Premsrirut, P. K., & He, J. C. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.03.016 · Cited by 50
Protective effects of Croton hookeri on streptozotocin-induced diabetic nephropathy
Kundu, A. B., Dey, P. K., Sarkar, P., Karmakar, S., Tae, I. H., Kim, K. S., Park, J. H., Lee, S. H., Lee, B. M., Renthlei, L., et al. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110873 · Cited by 53
Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications
Sehrawat, A., Mishra, J., Mastana, S. S., Navik, U., Bhatti, G. K., Reddy, P. H., & Bhatti, J. S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166666 · Cited by 50
Xu, Y. C., Liu, L., Xin, W., Zhao, X., Chen, L., Zhen, J., & Wan, Q. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.07.021 · Cited by 47
Metadata
- Authors
- Kitada, M., Takeda, A., Nagai, T., Ito, H., Kanasaki, K., & Koya, D.
- Affiliations
- Kanazawa Medical University (JP)
- Corresponding author
- Koya, Daisuke
- Venue
- Experimental Diabetes Research
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-11
- ISSN
- 1687-5214 (ISSN-L)
- 1687-5303
- PMC
- PMC3178150
- OpenAlex
- W2006254543
- Cited by
- 213
- References
- 29
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 6 · 2023: 13 · 2022: 19 · 2021: 25 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 13 · 2016: 18 · 2015: 12 · 2014: 12 · 2013: 21 · 2012: 6
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Experimental Diabetes Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Ministry of Health, Labour and Welfare (S2011-2)
- Uehara Memorial Foundation (S2011-2)
- Kanazawa Medical University (S2011-2)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- dietary restriction, diabetic nephropathy, type 2 diabetes, Wistar fatty rats, SIRT1, autophagy, NF-κB, renal inflammation, p62, mitochondrial morphology, proximal tubular epithelial cells, albuminuria, renal protection
- MeSH terms
- Albuminuria, Animals, Autophagy, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Diet, Reducing, Fibrosis, Inflammation, Kidney, Macrophages, Male, Rats, Wistar, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.